Change of NOMAD and broker

RNS Number : 2777I

Advanced Medical Solutions Grp PLC

17 November 2008

 



For Immediate Release        

17 November 2008 

Advanced Medical Solutions Group PLC

('AMS' or the 'Company')

Change of Nominated Adviser and Broker 

Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the global medical technology company,  confirms that, in accordance with AIM Rule 17, the Company's nominated adviser and broker is Teathers, a division of Straumur-Burdaras Investment Bank hf., of Berkeley Square House, Third Floor, Berkeley Square, London W1J 6BU.

For further information, please contact:

Advanced Medical Solutions Group plc
Don Evans, Chief Executive Officer Mary Tavener, Finance Director www.admedsol.com	Tel : [phone]
Buchanan Communications
Mark Court, Mary-Jane Johnson, Stasa Filiplic	Tel: [phone]
Teathers	Tel: [phone]
Shaun Dobson, Claes Spång

Notes to Editors:

Advanced Medical Solutions is a leading company in the development and manufacture of products for the $15 billion global woundcare market.

Founded in 1991 and quoted on AIM, Advanced Medical Solutions is focused on the design, development and manufacture of innovative and technologically advanced woundcare products.

In-house natural and synthetic polymer technology is used to provide advanced wound dressings based on the moist healing principle. AMS' resources ensure a unique position as a vertically integrated 'one stop shop' to provide all categories of moist wound healing products. The Company has the capability to move a product from design and development through to production and delivery for distribution and sale into customer markets.

The acquisition of 49.4% of Corpura BV in May 2008 strengthened AMS' position in hydrophilic polyurethane foam - the largest and fastest growing segment of the advanced woundcare market.

AMS' technology in cyanoacrylate based tissue adhesives is used either for the closure of small cuts and trauma wounds through to large surgical incisions, or for protecting or sealing skin to prevent breakdown or infection. 

AMS' products currently serve the majority of the key global markets sold either direct or through strategic partners or distributors.

 

END

 

 

APPBBBDBLGBGGIR